Source: BioPharma Dive

Maze: Metsera, Maze secure combined $415 million in IPOs

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go public.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jonathan Widawski's photo - Co-Founder & CEO of Maze

Co-Founder & CEO

Jonathan Widawski

CEO Approval Rating

90/100

Read more